A Stearic acid, zinc salt (8CI) CEP of the European Pharmacopoeia monograph is often referred to as a Stearic acid, zinc salt (8CI) Certificate of Suitability (COS). The purpose of a Stearic acid, zinc salt (8CI) CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Stearic acid, zinc salt (8CI) EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Stearic acid, zinc salt (8CI) to their clients by showing that a Stearic acid, zinc salt (8CI) CEP has been issued for it. The manufacturer submits a Stearic acid, zinc salt (8CI) CEP (COS) as part of the market authorization procedure, and it takes on the role of a Stearic acid, zinc salt (8CI) CEP holder for the record. Additionally, the data presented in the Stearic acid, zinc salt (8CI) CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Stearic acid, zinc salt (8CI) DMF.
A Stearic acid, zinc salt (8CI) CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Stearic acid, zinc salt (8CI) CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Stearic acid, zinc salt (8CI) suppliers with CEP (COS) on PharmaCompass.